(Q36450765)

14 August 2017

1 reference

title

Multimodality treatment of esophageal cancer: a review of the current status and future directions (English)

1 reference

14 August 2017

1 reference

Thomas Ng

1

1 reference

14 August 2017

Thomas Dipetrillo

series ordinal

2

1 reference

14 August 2017

John Purviance

series ordinal

3

1 reference

14 August 2017

Howard Safran

series ordinal

4

1 reference

14 August 2017

publication date

1 May 2006

1 reference

14 August 2017

published in

Current Oncology Reports

1 reference

14 August 2017

volume

8

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

174-182

1 reference

Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis

14 August 2017

cites work

1 reference

12 December 2020

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

12 December 2020

Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction

1 reference

12 December 2020

Management of esophageal cancer

1 reference

12 December 2020

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer

1 reference

12 December 2020

Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study

1 reference

12 December 2020

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

12 December 2020

Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer

1 reference

12 December 2020

Minimally invasive esophagectomy: outcomes in 222 patients.

1 reference

12 December 2020

Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results

1 reference

12 December 2020

Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

1 reference

12 December 2020

Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer

1 reference

12 December 2020

A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy

1 reference

12 December 2020

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

12 December 2020

A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction

1 reference

12 December 2020

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

1 reference

12 December 2020

Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus

1 reference

12 December 2020

Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF.

1 reference

12 December 2020

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

12 December 2020

Transhiatal esophagectomy: clinical experience and refinements

1 reference

12 December 2020

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.

1 reference

12 December 2020

Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters

1 reference

12 December 2020

The biology of vascular endothelial growth factor

1 reference

12 December 2020

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus

1 reference

12 December 2020

Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer

1 reference

12 December 2020

Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study.

1 reference

12 December 2020

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

1 reference

12 December 2020

Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer

1 reference

12 December 2020

Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus

1 reference

12 December 2020

Poly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX], a biodegradable polymeric drug conjugate: characterization, preclinical pharmacology, and preliminary clinical data

1 reference

12 December 2020

Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy

1 reference

12 December 2020

Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy

1 reference

12 December 2020

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus

1 reference

12 December 2020

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

1 reference

12 December 2020

Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy

1 reference

12 December 2020

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Investigation of taxol as a potential radiation sensitizer

1 reference

12 December 2020

Epidermal growth factor receptors: critical mediators of multiple receptor pathways

1 reference

12 December 2020

Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus

1 reference

12 December 2020

Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study

1 reference

12 December 2020

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

12 December 2020

Clinical translation of angiogenesis inhibitors

1 reference

12 December 2020

HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma

1 reference

12 December 2020

Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus

1 reference

12 December 2020

Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer

1 reference

12 December 2020

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

1 reference

12 December 2020

10.1007/S11912-006-0017-5

Identifiers

DOI

1 reference

14 August 2017

1 reference